Third Biennial International Eosinophil Symposium 2003

描述(由申请者提供)：第三届双年展国际嗜酸性粒细胞研讨会将于2003年6月25日至29日在科罗拉多州阿斯彭的斯诺马斯会议中心举行。这次研讨会是在国际嗜酸性粒细胞协会的赞助下举行的。会议将邀请35名特邀演讲者，24次额外的口头演讲(10分钟+5次讨论)和大约50张海报，这些海报将从提交的初级科学家(研究生、博士后研究员、初级教员)的摘要中挑选出来。预计将有200多名参与者有机会提交摘要，供选择进行口头或海报演示。组织委员会和计划委员会及其国际科学顾问委员会的成员正在准备一项关于基础、翻译和临床研究的尖端计划。这次会议提供了一个绝佳的机会，就这一生物医学重要、多样化和快速发展的领域的最新进展进行陈述和分组会议。会议由嗜酸性粒细胞研究和相关领域的领导人从哮喘、过敏、胃肠、血液学、肿瘤、纤维化和热带/寄生虫病的角度进行特邀演讲。重点将集中在嗜酸性粒细胞的细胞、分子和免疫生物学的基本方面，以及与嗜酸性粒细胞在正常生理、炎症和疾病发病机制中的作用相关的临床问题。其中包括关于嗜酸性粒细胞生物学在药物发现和嗜酸性粒细胞相关疾病的治疗中的应用的分组会议。会议形式为全体会议以及提交的摘要的口头和海报介绍提供了一个高度互动的研讨会形式的论坛，特别是年轻科学家(研究生、博士后研究员)提交的摘要。研讨会的主题包括：(1)嗜酸性粒细胞的发育、成熟、招募和迁移、启动和激活以及死亡；(2)嗜酸性粒细胞在哮喘、变态反应、热带疾病、组织重塑和纤维化、EMS、HES、嗜酸性粒细胞白血病和癌症生物学中的正常和病理生理作用；(3)嗜酸性粒细胞相关疾病和综合征的临床评价和治疗的当前问题；(4)嗜酸性粒细胞研究中未回答的问题和未来的方向。研讨会将实现以下目标：(1)为在不同组织级别和动物模型中研究嗜酸性粒细胞生物学的基础和临床科学家提供一个场所，以促进对它们在正常和病理生理条件下所起作用的理解；(2)将基础和临床研究人员聚集在一起，以促进基于对嗜酸性粒细胞免疫生物学和炎症功能的了解，开发嗜酸性粒细胞相关疾病的临床疗法、诊断测试和其他治疗方法；(3)通过包括许多来自提交的摘要的简短演讲，向与会者提供关于嗜酸性粒细胞基础和临床研究的最新信息，(4)为所有与会者提供机会，与演讲者和海报主持人深入讨论和交流意见，以实现交叉受精和建立基础与临床学科之间的合作；以及(5)为在过敏、免疫学、热带病、血液学和癌症研究领域工作的资深和有前途的初级科学家和少数群体提供一个互动论坛，就嗜酸性粒细胞在健康的正常生理和疾病的病理生理学中的作用进行有效的科学交流。

DESCRIPTION (provided by applicant): Partial financial support is requested for the 3rd Biennial International Eosinophil Symposium scheduled for June 25-29, 2003 at the Snowmass Conference Center, Snowmass Village Resort at Aspen, CO. The Symposium is being held under the auspices of the International Eosinophil Society. The meeting will host 35 invited featured speakers, and 24 additional oral talks (10 min + 5 rain discussion) and approximately 50 posters which will be selected from submitted abstracts of junior scientists (graduate students, postdoctoral fellows, junior faculty). More than 200 participants are anticipated who will have the opportunity to submit abstracts for selection for oral or poster presentations. A cutting edge program of basic, translational, and clinical research is being prepared by members of the Organizing and Program Committees and its International Scientific Advisory Board. The conference provides an outstanding opportunity for presentations and breakout sessions on the most recent advances in this biomedically important, diverse and rapidly advancing field. The meeting consists of invited talks by leaders in eosinophil research and allied fields from the perspectives of asthma, allergy, gastrointestinal, hematologic, neoplastic, fibrotic, and tropical/parasitic diseases. The focus will be on basic aspects of eosinophil cellular, molecular and immunobiology, and clinical issues relevant to the functions of eosinophils in both normal physiology, inflammation and disease pathogenesis. Opportunities are included for breakout sessions on applications of eosinophil biology to drug discovery and therapeutics for eosinophil-associated diseases. The meeting format provides a highly interactive, workshop-like forum for both the plenary talks, and the oral and poster presentations of submitted abstracts, especially by younger scientists (graduate students, postdoctoral fellows). The symposium covers the following major themes: (1) Eosinophil development, maturation, recruitment and migration, priming and activation, and death, (2) Normal versus pathophysiologic roles of eosinophils in asthma, allergy, tropical diseases, tissue remodeling and fibrosis, EMS, HES, eosinophil leukemia and cancer biology, (3) Current issues in the clinical evaluation/treatment of eosinophil-associated diseases and syndromes, (4) Unanswered questions and future directions in eosinophil research. The symposium will accomplish the following goals: (1) Provide a venue for bringing together basic and clinical scientists addressing eosinophil biology at different organizational levels and in animal models to foster understanding of their roles in normal versus pathophysiologic conditions, (2) Bring together basic and clinical investigators to foster the development of clinical therapeutics, diagnostic tests and other treatments of eosinophil-associated diseases based on understanding eosinophil immunobiology and inflammatory functions, (3) Provide participants with the latest information on eosinophil basic and clinical research by including many short talks from submitted abstracts, (4) Provide all participants with opportunities for in-depth discussions and exchange of ideas with speakers and poster presenters for cross-fertilization and establishment of collaborations between basic and clinical disciplines, and (5) Provide an interactive forum for effective scientific exchange amongst senior and promising junior scientists and minorities working in the fields of allergy, immunology, tropical diseases, hematology, and cancer research in terms of the functions of eosinophils in normal physiology in health and pathophysiology in disease.